Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathway analysis tools and toxicogenomics reference databases for risk assessment.

Brigitte Ganter1, Nadine Zidek, Philip R Hewitt

  • 1Ingenuity Systems, 1700 Seaport Blvd, Redwood City, CA 94063, USA. bganter@ingenuity.com

Pharmacogenomics
|December 25, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Digital profiling of gene expression from histology images with linearized attention.

Nature communications·2024
Same author

Effects of SGLT2 inhibitors on parameters of renal venous congestion in intrarenal Doppler ultrasonography.

Clinical kidney journal·2024
Same author

Figure Correction: Using Social Media to Help Understand Patient-Reported Health Outcomes of Post-COVID-19 Condition: Natural Language Processing Approach.

Journal of medical Internet research·2023
Same author

Graph-based multi-modality integration for prediction of cancer subtype and severity.

Scientific reports·2023
Same author

Digital profiling of cancer transcriptomes from histology images with grouped vision attention.

bioRxiv : the preprint server for biology·2023
Same author

Using Social Media to Help Understand Patient-Reported Health Outcomes of Post-COVID-19 Condition: Natural Language Processing Approach.

Journal of medical Internet research·2023
Same journal

Closely similar tacrolimus morning troughs and graft function across the recipients' common <i>ABCB1</i> polymorphisms (<i>c.2677G>T/A</i>, <i>c.1236C>T</i>, <i>c.3435C>T</i>) early after renal transplantation.

Pharmacogenomics·2026
Same journal

Pharmacogenomics for stratified antidepressant treatment in major depressive disorder: evidence, limits and a roadmap for clinical use.

Pharmacogenomics·2026
Same journal

Guidance from an informed public on collecting and sharing PGx test results for major depressive disorder: "It's no different from your blood type".

Pharmacogenomics·2026
Same journal

Optimizing pharmacogenomics workflows: a qualitative evaluation of clinical service delivery models.

Pharmacogenomics·2026
Same journal

Combinations of single gene predictors with AI-driven polygenic precision therapies in cardiovascular diseases.

Pharmacogenomics·2026
Same journal

Practical guide to implementing pre-emptive pharmacogenetic screening in routine pediatric oncology care.

Pharmacogenomics·2026
See all related articles

New toxicogenomics analysis integrates pathway and network tools with reference data. This approach enhances understanding of chemical toxicity mechanisms for improved drug discovery and risk assessment.

Area of Science:

  • Pharmaceutical Sciences
  • Toxicology
  • Bioinformatics

Background:

  • The pharmaceutical industry is integrating advanced technologies like proteomics, pharmacogenomics, metabolomics, and toxicogenomics into drug discovery.
  • Analyzing the large datasets generated by these technologies is crucial for understanding drug safety and efficacy.

Purpose of the Study:

  • To review the integrated analysis of toxicogenomics data using molecular pathway and network analysis tools combined with reference data.
  • To demonstrate how this approach enhances the understanding of chemical-induced toxicity mechanisms.
  • To illustrate the application of this knowledge in compound risk assessment during drug development.

Main Methods:

  • Analysis of toxicogenomics data using molecular pathway and network analysis tools.

Related Experiment Videos

  • Integration with reference data for comparative analysis.
  • Case study using lipopolysaccharide (LPS) to analyze hepatotoxicity in vivo and in vitro.

    • Main Results:

    • The combined approach provides deeper insights into molecular mechanisms of chemical toxicity.
    • Demonstrates the utility of integrated tools for analyzing complex in vivo and in vitro datasets.
    • Highlights the application of molecular toxicology in risk assessment.

    Conclusions:

    • Integrated analysis of toxicogenomics data improves the understanding of toxicity.
    • This approach aids in better lead selection and increases success rates in drug discovery and development.
    • Advanced analytical tools are essential for navigating complex biological data in pharmaceutical research.